// App-Quantinova.ai

4084 : Greek Registry Of Essential Thrombocythemia: Baseline Characteristics and Therapeutic Strategy

Researchers

Presenter

  • Damianos Sotiropoulos

Principal Investigators

  • Vassilios K Papadopoulos

  • Maria Kotsopoulou

  • Aikaterini Megalakaki

  • Charis Matsouka

  • Despina Barbarousi

  • Emmanouil S Papadakis

  • Aggeliki Vourtsi

  • Anastasia Pouli

  • Anastasia Sioni

  • Maria Protopapa

  • Aikaterini Bitzioni

  • Panagiotis Tsirigotis

  • Anna Pidagitou

  • Maria Dimou

  • Dimitris Tsokanas

  • Anthoula Bouchla

  • Chrysa Apostolou

  • Efthimia Vlachaki

  • Christos Georgopoulos

  • Nikolaos Anagnostopoulos

  • Evangelos Briasoulis

  • Achilles Anagnostopoulos

  • Maria Pagoni

  • Panayiotis Panayiotidis

  • Theodoros Marinakis

  • Amalia Vassou

  • Eleftheria Hatzimichael

  • Emmanouil Spanoudakis

  • Ioannis Kotsianidis

  • Alexandra Kouraklis

  • Polyxeni Lampropoulou

Medical Centers

  • Acute Leukemias and Myeloproliferative Neoplasms Study Group, Hellenic Society of Haematology, Greece

  • Acute Leukemias and Myeloproliferative Neoplasms Study Group, Hellenic Society of Haematology, Greece

Locations

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myeloid neoplasms

  • Essential thrombocythemia

  • Solid malignancies

  • Venous thrombosis

Biomarkers

  • N-Acylethanolamine acid amidase

  • White Blood Cell

Drug/Treatment

  • Hydroxyurea

  • Hydroxycarbamide

  • Clopidogrel bisulfate

  • Anagrelide hydrochloride

  • Interferon

  • Warfarin

  • Aspirin

  • Albyl-E

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved